» Articles » PMID: 26940867

Activation of Proto-oncogenes by Disruption of Chromosome Neighborhoods

Abstract

Oncogenes are activated through well-known chromosomal alterations such as gene fusion, translocation, and focal amplification. In light of recent evidence that the control of key genes depends on chromosome structures called insulated neighborhoods, we investigated whether proto-oncogenes occur within these structures and whether oncogene activation can occur via disruption of insulated neighborhood boundaries in cancer cells. We mapped insulated neighborhoods in T cell acute lymphoblastic leukemia (T-ALL) and found that tumor cell genomes contain recurrent microdeletions that eliminate the boundary sites of insulated neighborhoods containing prominent T-ALL proto-oncogenes. Perturbation of such boundaries in nonmalignant cells was sufficient to activate proto-oncogenes. Mutations affecting chromosome neighborhood boundaries were found in many types of cancer. Thus, oncogene activation can occur via genetic alterations that disrupt insulated neighborhoods in malignant cells.

Citing Articles

3D genome landscape of primary and metastatic colorectal carcinoma reveals the regulatory mechanism of tumorigenic and metastatic gene expression.

Xu X, Gan J, Gao Z, Li R, Huang D, Lin L Commun Biol. 2025; 8(1):365.

PMID: 40038385 PMC: 11880527. DOI: 10.1038/s42003-025-07647-2.


Molecular mechanisms altering cell identity in cancer.

Zippo A, Beyes S Oncogene. 2025; .

PMID: 40011573 DOI: 10.1038/s41388-025-03314-2.


Epigenetic priming promotes acquisition of tyrosine kinase inhibitor resistance and oncogene amplification in human lung cancer.

Starble R, Sun E, Gbyli R, Radda J, Lu J, Jensen T bioRxiv. 2025; .

PMID: 39974875 PMC: 11838195. DOI: 10.1101/2025.01.26.634826.


Multi-locus CRISPRi targeting with a single truncated guide RNA.

Moore M, Wekhande S, Issner R, Collins A, Cruz A, Liu Y Nat Commun. 2025; 16(1):1357.

PMID: 39905017 PMC: 11794626. DOI: 10.1038/s41467-025-56144-x.


The 3D genome and its impacts on human health and disease.

Wang S, Luo Z, Liu W, Hu T, Zhao Z, Rosenfeld M Life Med. 2025; 2(2):lnad012.

PMID: 39872109 PMC: 11749360. DOI: 10.1093/lifemedi/lnad012.


References
1.
Vogelstein B, Papadopoulos N, Velculescu V, Zhou S, Diaz Jr L, Kinzler K . Cancer genome landscapes. Science. 2013; 339(6127):1546-58. PMC: 3749880. DOI: 10.1126/science.1235122. View

2.
Van Vlierberghe P, Ferrando A . The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest. 2012; 122(10):3398-406. PMC: 3461904. DOI: 10.1172/JCI61269. View

3.
Vogelstein B, Kinzler K . Cancer genes and the pathways they control. Nat Med. 2004; 10(8):789-99. DOI: 10.1038/nm1087. View

4.
Mullighan C, Goorha S, Radtke I, Miller C, Coustan-Smith E, Dalton J . Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007; 446(7137):758-64. DOI: 10.1038/nature05690. View

5.
Loven J, Hoke H, Lin C, Lau A, Orlando D, Vakoc C . Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013; 153(2):320-34. PMC: 3760967. DOI: 10.1016/j.cell.2013.03.036. View